Veraxa Biotech AG (VRXA) files for 25M share offering by selling stockholders Jul 31, 2026 05:16PM
VERAXA Biotech files first BiTAC patent applications, portfolio tops 50 Jul 29, 2026 07:03AM
VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb Jul 27, 2026 07:00AM
Veraxa Biotech shareholders approve all EGM resolutions with 99.94% vote Jul 24, 2026 04:06PM
Veraxa Biotech names Christoph Erkel as chief scientific officer Jul 23, 2026 07:02AM


Jul 20, 2026 07:03AM Veraxa Biotech receives regulatory guidance on BiTAC-TCE cancer therapy
Jul 13, 2026 07:01AM VERAXA Biotech partners with Ardigen on AI drug discovery for cancer
Jul 6, 2026 07:01AM VERAXA Biotech targets first BiTAC candidate IND-ready by 2028
Jul 2, 2026 07:00AM Veraxa Biotech starts cell line development with ATUM for cancer therapy
Jun 24, 2026 07:00AM VERAXA Biotech expands lab space at Heidelberg R&D site
Jun 18, 2026 07:02AM VERAXA Biotech reports in vitro data for its BiTAC-ADC platform
Jun 10, 2026 04:15PM VERAXA Biotech completes merger, begins NASDAQ trading